Rational strain improvement for enhanced clavulanic acid production by genetic engineering of the glycolytic pathway in Streptomyces clavuligerus

Metabolic Engineering
Rongfeng Li, Craig A Townsend

Abstract

Clavulanic acid is a potent beta-lactamase inhibitor used to combat resistance to penicillin and cephalosporin antibiotics. There is a demand for high-yielding fermentation strains for industrial production of this valuable product. Clavulanic acid biosynthesis is initiated by the condensation of L-arginine and D-glyceraldehyde-3-phosphate (G3P). To overcome the limited G3P pool and improve clavulanic acid production, we genetically engineered the glycolytic pathway in Streptomyces clavuligerus. Two genes (gap1 and gap2) whose protein products are distinct glyceraldehyde-3-phosphate dehydrogenases (GAPDHs) were inactivated in S. clavuligerus by targeted gene disruption. A doubled production of clavulanic acid was consistently obtained when gap1 was disrupted, and reversed by complementation. Addition of arginine to the cultured mutant further improved clavulanic acid production giving a greater than 2-fold increase over wild type, suggesting that arginine became limiting for biosynthesis. This is the first reported application of genetic engineering to channel precursor flux to improve clavulanic acid production.

References

Jan 1, 1977·Annual Review of Microbiology·S W Drew, A L Demain
May 1, 1977·Antimicrobial Agents and Chemotherapy·C Reading, M Cole
May 3, 2002·European Journal of Biochemistry·Nadia J KershawChristopher J Schofield
Nov 5, 2002·Current Opinion in Chemical Biology·Craig A Townsend
Apr 8, 2003·Applied Microbiology and Biotechnology·R P Elander

❮ Previous
Next ❯

Citations

Jan 9, 2009·Bioscience, Biotechnology, and Biochemistry·Sae-Jin KimChan-Wha Kim
Mar 17, 2009·Applied and Environmental Microbiology·Sonia BañosPaloma Liras
Jul 29, 2010·The Journal of Antibiotics·Sergio SánchezBeatriz Ruiz
Nov 10, 2006·Bioprocess and Biosystems Engineering·S ChhatreE Keshavarz-Moore
Aug 17, 2010·Applied Microbiology and Biotechnology·Ju Yeon SongKye Joon Lee
Mar 13, 2012·Applied Microbiology and Biotechnology·Di HuangYunlin Chen
Aug 1, 2008·Expert Opinion on Drug Discovery·Nishikant V Wase, Phillip C Wright
Dec 12, 2012·Biotechnology Advances·Gulay Ozcengiz, Arnold L Demain
Jul 15, 2015·Biotechnology Progress·Claudia SánchezSilvia Ochoa
Aug 30, 2008·Current Opinion in Biotechnology·Kristala L Jones Prather, Collin H Martin
Sep 9, 2008·Drug Discovery Today·Sang Yup LeeTae Yong Kim
May 3, 2008·Biotechnology Advances·Parag S SaudagarRekha S Singhal
Aug 20, 2015·Applied Microbiology and Biotechnology·Anaya Raj PokhrelJae Kyung Sohng
Sep 23, 2014·Biological Reviews of the Cambridge Philosophical Society·Anna StinconeMarkus Ralser
Dec 9, 2014·Bioengineered·Valerie BekkerKarl Rumbold
Feb 18, 2011·Bioengineered Bugs·Jose-Luis Adrio, Arnold L Demain
Sep 28, 2010·Microbiological Research·Hum Nath JnawaliJae Kyung Sohng
May 17, 2011·Microbiological Research·Sarita PaudelJae Kyung Sohng
Apr 14, 2016·Natural Product Reports·Mingzi M ZhangHuimin Zhao
Jul 19, 2018·Antibiotics·Daniela de Araújo Viana MarquesAna Lúcia Figueiredo Porto
Nov 23, 2007·Natural Product Reports·J Stefan RokemJens Nielsen
Jan 27, 2009·The Journal of Antibiotics·Hum Nath JnawaliJae Kyung Sohng
Jul 9, 2008·The Journal of Biological Chemistry·Irina BorodinaJens Nielsen
Nov 9, 2012·Natural Product Reports·Refaat B HamedChristopher J Schofield
Jul 30, 2019·Frontiers in Microbiology·Erick Eligio Arroyo-PérezLuis Servín-González
Jan 19, 2020·Folia Microbiologica·Oscar F Hernández-SaldañaLuz E Casados-Vázquez
Jan 27, 2019·Applied Biochemistry and Biotechnology·K C S RodriguesM O Cerri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.